Teva Pharms Inc Drug Patent Portfolio
Teva Pharms Inc owns 1 orange book drug protected by 1 US patent Given below is the list of Teva Pharms Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11072586 | Solid state forms of eltrombopag choline | 05 Nov, 2038 | Active |
Teva Pharms Inc's Family Patents
Recent FDA approvals and tentative approvals for Teva Pharms Inc
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Sheur |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 22 Sep, 2025 |
| Nintedanib |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 15 Aug, 2025 |
| Azacitidine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 10 Apr, 2025 |
Teva Pharms Inc Drug List
Given below is the complete list of Teva Pharms Inc's drugs and the patents protecting them.
1. Alvaiz
Alvaiz is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11072586 | Solid state forms of eltrombopag choline |
05 Nov, 2038
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alvaiz's drug page